"Breakthrough Blood Test Predicts Breast Cancer Recurrence with 100% Accuracy"
Originally Published 1 year ago — by The Guardian
A new blood test using whole genome sequencing can predict the risk of breast cancer returning up to three years before tumors appear on scans. This breakthrough, presented at the American Society of Clinical Oncology annual meeting, could help identify which women need preventive therapy and improve early treatment, significantly increasing the chances of beating the disease. Researchers found the test to be highly sensitive, accurately predicting relapse in all trial patients who later experienced recurrence.